T7 rna polymerase variants with cysteine-serine substitutions
AssigneeRoche Diagnostics Operations, Inc.
InventorsMichael Greif, Christian Rudolph, Manfred Schmidt, Harald Sobek, Johann-Peter Thalhofer
Life of this patent
Estimating the term…
Loading patent…
AssigneeRoche Diagnostics Operations, Inc.
InventorsMichael Greif, Christian Rudolph, Manfred Schmidt, Harald Sobek, Johann-Peter Thalhofer
Estimating the term…
The present disclosure provide novel variants of T7 RNA polymerase. Embodiments of T7 variants, according to the instant invention, include a Cysteine-Serine substitution on position 723 of the amino acid sequence of the T7 polypeptide. Embodiments of T7 variants according to the instant invention have a DNA-dependent RNA polymerase enzymatic activity and a reduced tendency to form intramolecular homodimers by way of oxidizing thiol groups. The amino acid substitutions within the T7 variants disclosed herein impact minimally, if at all, the RNA polymerase activity of the T7 polypeptide. Further, the mutations of the disclosed embodiments may optionally be combined with mutations which provide enhanced thermostability compared to the wild-type reference.
An aqueous solution being devoid of a reducing agent with a thiol group, the aqueous solution comprising:
A method of producing an aqueous solution devoid of a reducing agent including a thiol group, the solution comprising a variant of T7 RNA polymerase having DNA-dependent RNA polymerase activity and an amino acid sequence different from SEQ ID NO:2, the variant being devoid of homomultimer formation of intermolecular disulfide bonds when in the solution, the method comprising the steps of:
A method of synthesizing a RNA molecule, comprising the steps of:
Dependencies are inferred from the claim text.